Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

In silico study of alkaloids with quercetin nucleus for inhibition of SARS-CoV-2 protease and receptor cell protease

Mohebbi et al., PLOS ONE, doi:10.1371/journal.pone.0298201
Apr 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Quercetin for COVID-19
24th treatment shown to reduce risk in July 2021, now with p = 0.002 from 12 studies.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
In Silico study showing that the alkaloids with a quercetin nucleus may inhibit SARS-CoV-2 infection by binding to the main protease (Mpro) and the host cell protease TMPRSS2. Molecular docking analysis found three compounds, Phyllospadine, Dracocephin-A, and Prolinalin-A, had the strongest binding affinity for Mpro and TMPRSS2 out of seven tested alkaloids with a quercetin nucleus. Molecular dynamics simulations confirmed stable binding of Phyllospadine and Dracocephin-A to both Mpro and TMPRSS2, while Prolinalin-A bound stably to Mpro but caused some structural instability of TMPRSS2. Authors conclude that Phyllospadine, Dracocephin-A, and Prolinalin-A are promising candidates for development as drugs to treat SARS-CoV-2 infection.
Mohebbi et al., 16 Apr 2024, peer-reviewed, 4 authors. Contact: amohebbi@uk.ac.ir, amohebbi2002@yahoo.com.
In Silico studies are an important part of preclinical research, however results may be very different in vivo.
This PaperQuercetinAll
In silico study of alkaloids with quercetin nucleus for inhibition of SARS-CoV-2 protease and receptor cell protease
Ali Mohebbi, Marzieh Eskandarzadeh, Hanieh Zangi, Marzie Fatehi
PLOS ONE, doi:10.1371/journal.pone.0298201
Covid-19 disease caused by the deadly SARS-CoV-2 virus is a serious and threatening global health issue declared by the WHO as an epidemic. Researchers are studying the design and discovery of drugs to inhibit the SARS-CoV-2 virus due to its high mortality rate. The main Covid-19 virus protease (Mpro) and human transmembrane protease, serine 2 (TMPRSS2) are attractive targets for the study of antiviral drugs against SARS-2 coronavirus. Increasing consumption of herbal medicines in the community and a serious approach to these drugs have increased the demand for effective herbal substances. Alkaloids are one of the most important active ingredients in medicinal plants that have wide applications in the pharmaceutical industry. In this study, seven alkaloid ligands with Quercetin nucleus for the inhibition of Mpro and TMPRSS2 were studied using computational drug design including molecular docking and molecular dynamics simulation (MD). Auto Dock software was used to evaluate molecular binding energy. Three ligands with the most negative docking score were selected to be entered into the MD simulation procedure. To evaluate the protein conformational changes induced by tested ligands and calculate the binding energy between the ligands and target proteins, GROMACS software based on AMBER03 force field was used. The MD results showed that Phyllospadine and Dracocephin-A form stable complexes with Mpro and TMPRSS2. Prolinalin-A indicated an acceptable inhibitory effect on Mpro, whereas it resulted in some structural instability of TMPRSS2. The total binding energies between three ligands, Prolinalin-A, Phyllospadine and Dracocephin-A and two proteins MPro and TMRPSS2 are (-111.235 ± 15.877, -75.422 ± 11.140), (-107.033 ± 9.072, -84.939 ± 10.155) and (-102.941 ± 9.477, -92.451 ± 10.539), respectively. Since the binding energies are at a minimum, this indicates confirmation of the proper binding of the ligands to the proteins. Regardless of some Prolinalin-A-induced TMPRSS2 conformational changes, it may properly bind to TMPRSS2 binding site due to its acceptable binding energy. Therefore, these three ligands can be promising candidates for the development of drugs to treat infections caused by the SARS-CoV-2 virus.
Author Contributions Conceptualization: Ali Mohebbi, Marzieh Eskandarzadeh, Marzie Fatehi.
References
Alzain, Elbadwi, Identification of novel TMPRSS2 inhibitors for COVID-19 using e-pharmacophore modelling, molecular docking, molecular dynamics and quantum mechanics studies, Informatics in Medicine Unlocked, doi:10.1016/j.imu.2021.100758
Berman, Westbrook, Feng, Gilliland, Bhat et al., The Protein Data Bank, Nucleic Acids Research, doi:10.1093/nar/28.1.235
Bhambhani, Kondhare, Giri, Diversity in chemical structures and biological properties of plant alkaloids, Molecules, doi:10.3390/molecules26113374
Bushehri, Mohebbi, Rafsanjani, Prediction of thermal conductivity and viscosity of nanofluids by molecular dynamics simulation, Journal of Engineering Thermophysics
Byle ´hn, Modeling the binding mechanism of remdesivir, favilavir, and ribavirin to SARS-CoV-2 RNA-dependent RNA polymerase, ACS Central Science, doi:10.1021/acscentsci.0c01242
Esam, In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19, Chemical Papers
Eskandarzadeh, Inhibition of GSK_3β by Iridoid Glycosides of Snowberry (Symphoricarpos albus) Effective in the Treatment of Alzheimer's Disease Using Computational Drug Design Methods, Frontiers in Chemistry
Fatehi, Mohebbi, Molecular dynamics insight into the behaviour of 5-nonylsalicylaldoxime and its complex with Cu (II) in different diluent/water systems, Journal of Molecular Liquids
Fehr, Perlman, Coronaviruses: An Overview of Their Replication and Pathogenesis (Book Chapter), Coronaviruses: Methods and Protocols
Firouzi, Ashouri, Karimi-Jafari, Structural insights into the substrate-binding site of main protease for the structure-based COVID-19 drug discovery, Proteins: Structure, Function, and Bioinformatics, doi:10.1002/prot.26318
Forli, Computational protein-ligand docking and virtual drug screening with the AutoDock suite, Nature Protocols, doi:10.1038/nprot.2016.051
Fraser, Structure, activity and inhibition of human TMPRSS2, a protease implicated in SARS-CoV-2 activation, BioRxiv
Friedman, Potato glycoalkaloids and metabolites: roles in the plant and in the diet, Journal of Agricultural and Food Chemistry, doi:10.1021/jf061471t
Gharaghani, Khayamian, Ebrahimi, Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors, SAR and QSAR in Environmental Research, doi:10.1080/1062936X.2013.792877
Gonzalez, The naturally-derived alkaloids as a potential treatment for COVID-19: A scoping review, Phytotherapy Research, doi:10.1002/ptr.7442
Gyebi, Prevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2, J Biomol Struct Dyn
Hanwell, Avogadro: an advanced semantic chemical editor, visualization, and analysis platform, Journal of Cheminformatics
Hoffmann, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cells, doi:10.1016/j.cell.2020.02.052
Huang, Pharmacological therapeutics targeting RNA-dependent RNA polymerase, proteinase and spike protein: from mechanistic studies to clinical trials for COVID-19, Journal of Clinical Medicine, doi:10.3390/jcm9041131
Hussain, Structural basis of SARS-CoV-2 spike protein priming by TMPRSS2, BioRxiv
Idris, Computer-aided screening for potential TMPRSS2 inhibitors: a combination of pharmacophore modeling, molecular docking and molecular dynamics simulation approaches, Journal of Biomolecular Structure and Dynamics, doi:10.1080/07391102.2020.1792346
Kermani, Mohebbi, Optimal loading of omecamtiv mecarbil by chitosan: A comprehensive and comparative molecular dynamics study, Journal of Molecular Liquids
Kianipour, A molecular dynamics study on using of naturally occurring polymers for structural stabilization of erythropoietin at high temperature, Journal of Biomolecular Structure and Dynamics
Kneller, Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography, Nature Communications, doi:10.1038/s41467-020-16954-7
Lee, Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site, Nature Communications, doi:10.1038/s41467-020-19662-4
Liang, Characterization and inhibition of SARS-coronavirus main protease, Current Topics in Medicinal Chemistry, doi:10.2174/156802606776287090
Lindahl, Hess, Van Der, Spoel, None, GROMACS
Majnooni, Alkaloids as potential phytochemicals against SARS-CoV-2: approaches to the associated pivotal mechanisms, Evidence-based Complementary and Alternative Medicine
Majumder, Mandal, Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach, Journal of Biomolecular Structure and Dynamics
Mantzourani, The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19, Expert Opinion on Drug Discovery, doi:10.1080/17460441.2022.2029843
Nguyen, Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris, Biotechnol Lett, doi:10.1007/s10529-011-0845-8
Odega, Iyamah, Ibadin, Idomeh, Odega, Safe laboratory practices in the light of Covid-19 pandemic: way forward in a resource limited setting, Preprints, doi:10.20944/preprints202004.0103.v1
Padhi, Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations, European Journal of Pharmacology, doi:10.1016/j.ejphar.2020.173836
Pourmand, Inhibition of SARS-CoV-2 pathogenesis by potent peptides designed by the mutation of ACE2 binding region, Computers in Biology and Medicine, doi:10.1016/j.compbiomed.2022.105625
Povs, Rare tradition of the folk medicinal use of Aconitum spp. is kept alive in Solčavsko, Slovenia, Journal of Ethnobiology and Ethnomedicine
Raschka, Protein-ligand interfaces are polarized: discovery of a strong trend for intermolecular hydrogen bonds to favor donors on the protein side with implications for predicting and designing ligand complexes, Journal of Computer-Aided Molecular Design, doi:10.1007/s10822-018-0105-2
Saakre, Mathew, Ravisankar, Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2, Beni-Suef University Journal of Basic and Applied Sciences, doi:10.1186/s43088-021-00107-w
Sajed, Amgain, Corona virus disease (COVID-19) outbreak and the strategy for prevention, Europasian Journal of Medical Sciences
Senger, COVID-19: molecular targets, drug repurposing and new avenues for drug discovery, Memo ´rias do Instituto Oswaldo Cruz, doi:10.1590/0074-02760200254
Shukla, Munjal, Singh, Identification of novel small molecules against GSK3β for Alzheimer's disease using chemoinformatics approach, Journal of Molecular Graphics and Modelling
Singh, ACE2 and TMPRSS2 polymorphisms in various diseases with special reference to its impact on COVID-19 disease, Microbial Pathogenesis, doi:10.1016/j.micpath.2020.104621
Thawabteh, The biological activity of natural alkaloids against herbivores, cancerous cells and pathogens, Toxins, doi:10.3390/toxins11110656
Vincent, Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, Virology Journal, doi:10.1186/1743-422X-2-69
Wang, Structure of main protease from human coronavirus NL63: insights for wide spectrum anti-coronavirus drug design, Scientific Reports, doi:10.1038/srep22677
Wink, Potential of DNA intercalating alkaloids and other plant secondary metabolites against SARS-CoV-2 causing COVID-19, Diversity
Woo, Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus, Journal of Virology, doi:10.1128/JVI.06540-11
Wu, Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods, Acta Pharmaceutica Sinica B, doi:10.1016/j.apsb.2020.02.008
Xia, Kang, Activation and maturation of SARS-CoV main protease, Protein & Cell, doi:10.1007/s13238-011-1034-1
Yadav, Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19, Cells, doi:10.3390/cells10040821
Yamamoto, COVID-19: Review of a 21st century pandemic from etiology to neuro-psychiatric implications, Journal of Alzheimer's Disease, doi:10.3233/JAD-200831
Zarei, In silico evaluation of COVID-19 main protease interactions with honeybee natural products for discovery of high potential antiviral compounds, Natural Product Research
Zhang, Li, Niu, ACE2 and COVID-19 and the resulting ARDS, Postgraduate Medical Journal, doi:10.1136/postgradmedj-2020-137935
Zhang, Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy, Signal Transduction and Targeted Therapy, doi:10.1038/s41392-021-00653-w
Zhao, Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332, Protein & Cell, doi:10.1007/s13238-021-00883-2
{ 'indexed': {'date-parts': [[2024, 4, 17]], 'date-time': '2024-04-17T00:45:27Z', 'timestamp': 1713314727239}, 'reference-count': 55, 'publisher': 'Public Library of Science (PLoS)', 'issue': '4', 'license': [ { 'start': { 'date-parts': [[2024, 4, 16]], 'date-time': '2024-04-16T00:00:00Z', 'timestamp': 1713225600000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by/4.0/'}], 'content-domain': {'domain': ['www.plosone.org'], 'crossmark-restriction': False}, 'abstract': '<jats:p>Covid-19 disease caused by the deadly SARS-CoV-2 virus is a serious and threatening ' 'global health issue declared by the WHO as an epidemic. Researchers are studying the design ' 'and discovery of drugs to inhibit the SARS-CoV-2 virus due to its high mortality rate. The ' 'main Covid-19 virus protease (Mpro) and human transmembrane protease, serine 2 (TMPRSS2) are ' 'attractive targets for the study of antiviral drugs against SARS-2 coronavirus. Increasing ' 'consumption of herbal medicines in the community and a serious approach to these drugs have ' 'increased the demand for effective herbal substances. Alkaloids are one of the most important ' 'active ingredients in medicinal plants that have wide applications in the pharmaceutical ' 'industry. In this study, seven alkaloid ligands with Quercetin nucleus for the inhibition of ' 'Mpro and TMPRSS2 were studied using computational drug design including molecular docking and ' 'molecular dynamics simulation (MD). Auto Dock software was used to evaluate molecular binding ' 'energy. Three ligands with the most negative docking score were selected to be entered into ' 'the MD simulation procedure. To evaluate the protein conformational changes induced by tested ' 'ligands and calculate the binding energy between the ligands and target proteins, GROMACS ' 'software based on AMBER03 force field was used. The MD results showed that Phyllospadine and ' 'Dracocephin-A form stable complexes with Mpro and TMPRSS2. Prolinalin-A indicated an ' 'acceptable inhibitory effect on Mpro, whereas it resulted in some structural instability of ' 'TMPRSS2. The total binding energies between three ligands, Prolinalin-A, Phyllospadine and ' 'Dracocephin-A and two proteins MPro and TMRPSS2 are (-111.235 ± 15.877, - 75.422 ± 11.140), ' '(-107.033 ± 9.072, -84.939 ± 10.155) and (-102.941 ± 9.477, - 92.451 ± 10.539), respectively. ' 'Since the binding energies are at a minimum, this indicates confirmation of the proper ' 'binding of the ligands to the proteins. Regardless of some Prolinalin-A-induced TMPRSS2 ' 'conformational changes, it may properly bind to TMPRSS2 binding site due to its acceptable ' 'binding energy. Therefore, these three ligands can be promising candidates for the ' 'development of drugs to treat infections caused by the SARS-CoV-2 virus.</jats:p>', 'DOI': '10.1371/journal.pone.0298201', 'type': 'journal-article', 'created': {'date-parts': [[2024, 4, 16]], 'date-time': '2024-04-16T17:57:25Z', 'timestamp': 1713290245000}, 'page': 'e0298201', 'update-policy': 'http://dx.doi.org/10.1371/journal.pone.corrections_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'In silico study of alkaloids with quercetin nucleus for inhibition of SARS-CoV-2 protease and ' 'receptor cell protease', 'prefix': '10.1371', 'volume': '19', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-2303-7231', 'authenticated-orcid': True, 'given': 'Ali', 'family': 'Mohebbi', 'sequence': 'first', 'affiliation': []}, {'given': 'Marzieh', 'family': 'Eskandarzadeh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hanieh', 'family': 'Zangi', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-9687-2182', 'authenticated-orcid': True, 'given': 'Marzie', 'family': 'Fatehi', 'sequence': 'additional', 'affiliation': []}], 'member': '340', 'published-online': {'date-parts': [[2024, 4, 16]]}, 'reference': [ { 'key': 'pone.0298201.ref001', 'first-page': '1', 'volume-title': 'Coronaviruses: An Overview of Their Replication and Pathogenesis (Book ' 'Chapter), Coronaviruses: Methods and Protocols', 'author': 'A.R. Fehr', 'year': '2015'}, { 'key': 'pone.0298201.ref002', 'first-page': '2020040103', 'article-title': 'Safe laboratory practices in the light of Covid-19 pandemic: way ' 'forward in a resource limited setting', 'author': 'K. Odega', 'year': '2020', 'journal-title': 'Preprints'}, { 'issue': '5', 'key': 'pone.0298201.ref003', 'doi-asserted-by': 'crossref', 'first-page': '766', 'DOI': '10.1016/j.apsb.2020.02.008', 'article-title': 'Analysis of therapeutic targets for SARS-CoV-2 and discovery of ' 'potential drugs by computational methods', 'volume': '10', 'author': 'C. Wu', 'year': '2020', 'journal-title': 'Acta Pharmaceutica Sinica B'}, { 'issue': '16', 'key': 'pone.0298201.ref004', 'doi-asserted-by': 'crossref', 'first-page': '4254', 'DOI': '10.1080/14786419.2021.1974435', 'article-title': 'In silico evaluation of COVID-19 main protease interactions with ' 'honeybee natural products for discovery of high potential antiviral ' 'compounds', 'volume': '36', 'author': 'A. Zarei', 'year': '2022', 'journal-title': 'Natural Product Research'}, { 'issue': '1', 'key': 'pone.0298201.ref005', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.46405/ejms.v2i1.38', 'article-title': 'Corona virus disease (COVID-19) outbreak and the strategy for ' 'prevention', 'volume': '2', 'author': 'A.N. Sajed', 'year': '2020', 'journal-title': 'Europasian Journal of Medical Sciences'}, { 'key': 'pone.0298201.ref006', 'article-title': 'Structural basis of SARS-CoV-2 spike protein priming by TMPRSS2', 'author': 'M. Hussain', 'year': '2020', 'journal-title': 'BioRxiv'}, { 'issue': '2', 'key': 'pone.0298201.ref007', 'doi-asserted-by': 'crossref', 'first-page': '459', 'DOI': '10.3233/JAD-200831', 'article-title': 'COVID-19: Review of a 21st century pandemic from etiology to ' 'neuro-psychiatric implications', 'volume': '77', 'author': 'V. Yamamoto', 'year': '2020', 'journal-title': 'Journal of Alzheimer’s Disease'}, { 'issue': '4', 'key': 'pone.0298201.ref008', 'doi-asserted-by': 'crossref', 'first-page': '821', 'DOI': '10.3390/cells10040821', 'article-title': 'Role of structural and non-structural proteins and therapeutic targets ' 'of SARS-CoV-2 for COVID-19', 'volume': '10', 'author': 'R. Yadav', 'year': '2021', 'journal-title': 'Cells'}, { 'issue': '4', 'key': 'pone.0298201.ref009', 'doi-asserted-by': 'crossref', 'first-page': '1131', 'DOI': '10.3390/jcm9041131', 'article-title': 'Pharmacological therapeutics targeting RNA-dependent RNA polymerase, ' 'proteinase and spike protein: from mechanistic studies to clinical ' 'trials for COVID-19', 'volume': '9', 'author': 'J. Huang', 'year': '2020', 'journal-title': 'Journal of Clinical Medicine'}, { 'issue': '1', 'key': 'pone.0298201.ref010', 'doi-asserted-by': 'crossref', 'first-page': '233', 'DOI': '10.1038/s41392-021-00653-w', 'article-title': 'Molecular mechanism of interaction between SARS-CoV-2 and host cells ' 'and interventional therapy', 'volume': '6', 'author': 'Q. Zhang', 'year': '2021', 'journal-title': 'Signal Transduction and Targeted Therapy'}, { 'issue': '1137', 'key': 'pone.0298201.ref011', 'doi-asserted-by': 'crossref', 'first-page': '403', 'DOI': '10.1136/postgradmedj-2020-137935', 'article-title': 'ACE2 and COVID-19 and the resulting ARDS', 'volume': '96', 'author': 'X. Zhang', 'year': '2020', 'journal-title': 'Postgraduate Medical Journal'}, { 'key': 'pone.0298201.ref012', 'doi-asserted-by': 'crossref', 'DOI': '10.1590/0074-02760200254', 'article-title': 'COVID-19: molecular targets, drug repurposing and new avenues for drug ' 'discovery', 'volume': '115', 'author': 'M.R. Senger', 'year': '2020', 'journal-title': 'Memórias do Instituto Oswaldo Cruz'}, { 'issue': '3', 'key': 'pone.0298201.ref013', 'doi-asserted-by': 'crossref', 'first-page': '231', 'DOI': '10.1080/17460441.2022.2029843', 'article-title': 'The discovery and development of transmembrane serine protease 2 ' '(TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19', 'volume': '17', 'author': 'C. Mantzourani', 'year': '2022', 'journal-title': 'Expert Opinion on Drug Discovery'}, { 'issue': '2', 'key': 'pone.0298201.ref014', 'doi-asserted-by': 'crossref', 'first-page': '271', 'DOI': '10.1016/j.cell.2020.02.052', 'article-title': 'SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a ' 'clinically proven protease inhibitor', 'volume': '181', 'author': 'M. Hoffmann', 'year': '2020', 'journal-title': 'Cells'}, { 'issue': '1', 'key': 'pone.0298201.ref015', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/1743-422X-2-69', 'article-title': 'Chloroquine is a potent inhibitor of SARS coronavirus infection and ' 'spread', 'volume': '2', 'author': 'M.J. Vincent', 'year': '2005', 'journal-title': 'Virology Journal'}, { 'key': 'pone.0298201.ref016', 'doi-asserted-by': 'crossref', 'first-page': '831', 'DOI': '10.1007/s10529-011-0845-8', 'article-title': 'Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease ' 'expressed in Pichia pastoris', 'volume': '34', 'author': 'T.T.H Nguyen', 'year': '2012', 'journal-title': 'Biotechnol Lett'}, { 'key': 'pone.0298201.ref017', 'doi-asserted-by': 'crossref', 'first-page': '104621', 'DOI': '10.1016/j.micpath.2020.104621', 'article-title': 'ACE2 and TMPRSS2 polymorphisms in various diseases with special ' 'reference to its impact on COVID-19 disease', 'volume': '150', 'author': 'H. Singh', 'year': '2021', 'journal-title': 'Microbial Pathogenesis'}, { 'issue': '2', 'key': 'pone.0298201.ref018', 'doi-asserted-by': 'crossref', 'first-page': '1129', 'DOI': '10.1007/s11696-022-02528-y', 'article-title': 'In silico investigation of the therapeutic and prophylactic potential ' 'of medicinal substances bearing guanidine moieties against COVID-19', 'volume': '77', 'author': 'Z. Esam', 'year': '2023', 'journal-title': 'Chemical Papers'}, { 'issue': '1', 'key': 'pone.0298201.ref019', 'doi-asserted-by': 'crossref', 'first-page': '164', 'DOI': '10.1021/acscentsci.0c01242', 'article-title': 'Modeling the binding mechanism of remdesivir, favilavir, and ribavirin ' 'to SARS-CoV-2 RNA-dependent RNA polymerase', 'volume': '7', 'author': 'F. Byléhn', 'year': '2021', 'journal-title': 'ACS Central Science'}, { 'issue': '1', 'key': 'pone.0298201.ref020', 'doi-asserted-by': 'crossref', 'first-page': '22677', 'DOI': '10.1038/srep22677', 'article-title': 'Structure of main protease from human coronavirus NL63: insights for ' 'wide spectrum anti-coronavirus drug design', 'volume': '6', 'author': 'F. Wang', 'year': '2016', 'journal-title': 'Scientific Reports'}, { 'issue': '4', 'key': 'pone.0298201.ref021', 'doi-asserted-by': 'crossref', 'first-page': '361', 'DOI': '10.2174/156802606776287090', 'article-title': 'Characterization and inhibition of SARS-coronavirus main protease', 'volume': '6', 'author': 'P.-H. Liang', 'year': '2006', 'journal-title': 'Current Topics in Medicinal Chemistry'}, { 'issue': '7811', 'key': 'pone.0298201.ref022', 'doi-asserted-by': 'crossref', 'first-page': '289', 'DOI': '10.1038/s41586-020-2223-y', 'article-title': 'Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors', 'volume': '582', 'author': 'Z. Jin', 'year': '2020', 'journal-title': 'Nature'}, { 'issue': '1', 'key': 'pone.0298201.ref023', 'doi-asserted-by': 'crossref', 'first-page': '5877', 'DOI': '10.1038/s41467-020-19662-4', 'article-title': 'Crystallographic structure of wild-type SARS-CoV-2 main protease ' 'acyl-enzyme intermediate with physiological C-terminal autoprocessing ' 'site', 'volume': '11', 'author': 'J. Lee', 'year': '2020', 'journal-title': 'Nature Communications'}, { 'issue': '9', 'key': 'pone.0298201.ref024', 'doi-asserted-by': 'crossref', 'first-page': '689', 'DOI': '10.1007/s13238-021-00883-2', 'article-title': 'Crystal structure of SARS-CoV-2 main protease in complex with protease ' 'inhibitor PF-07321332', 'volume': '13', 'author': 'Y. Zhao', 'year': '2022', 'journal-title': 'Protein & Cell'}, { 'issue': '1', 'key': 'pone.0298201.ref025', 'doi-asserted-by': 'crossref', 'first-page': '3202', 'DOI': '10.1038/s41467-020-16954-7', 'article-title': 'Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity ' 'revealed by room temperature X-ray crystallography', 'volume': '11', 'author': 'D.W. Kneller', 'year': '2020', 'journal-title': 'Nature Communications'}, { 'issue': '7', 'key': 'pone.0298201.ref026', 'doi-asserted-by': 'crossref', 'first-page': '3995', 'DOI': '10.1128/JVI.06540-11', 'article-title': 'Discovery of seven novel Mammalian and avian coronaviruses in the genus ' 'deltacoronavirus supports bat coronaviruses as the gene source of ' 'alphacoronavirus and betacoronavirus and avian coronaviruses as the ' 'gene source of gammacoronavirus and deltacoronavirus', 'volume': '86', 'author': 'P.C. Woo', 'year': '2012', 'journal-title': 'Journal of Virology'}, { 'issue': '4', 'key': 'pone.0298201.ref027', 'doi-asserted-by': 'crossref', 'first-page': '282', 'DOI': '10.1007/s13238-011-1034-1', 'article-title': 'Activation and maturation of SARS-CoV main protease', 'volume': '2', 'author': 'B. Xia', 'year': '2011', 'journal-title': 'Protein & Cell'}, { 'issue': '2', 'key': 'pone.0298201.ref028', 'doi-asserted-by': 'crossref', 'first-page': '696', 'DOI': '10.1080/07391102.2020.1817787', 'article-title': 'Screening of plant-based natural compounds as a potential COVID-19 main ' 'protease inhibitor: an in silico docking and molecular dynamics ' 'simulation approach', 'volume': '40', 'author': 'R. Majumder', 'year': '2022', 'journal-title': 'Journal of Biomolecular Structure and Dynamics'}, { 'issue': '5', 'key': 'pone.0298201.ref029', 'doi-asserted-by': 'crossref', 'first-page': '175', 'DOI': '10.3390/d12050175', 'article-title': 'Potential of DNA intercalating alkaloids and other plant secondary ' 'metabolites against SARS-CoV-2 causing COVID-19', 'volume': '12', 'author': 'M. Wink', 'year': '2020', 'journal-title': 'Diversity'}, { 'issue': '7', 'key': 'pone.0298201.ref030', 'doi-asserted-by': 'crossref', 'first-page': '2686', 'DOI': '10.1002/ptr.7442', 'article-title': 'The naturally‐derived alkaloids as a potential treatment for COVID‐19: ' 'A scoping review', 'volume': '36', 'author': 'B.L. Gonzalez', 'year': '2022', 'journal-title': 'Phytotherapy Research'}, { 'key': 'pone.0298201.ref031', 'doi-asserted-by': 'crossref', 'DOI': '10.1155/2021/6632623', 'article-title': 'Alkaloids as potential phytochemicals against SARS-CoV-2: approaches to ' 'the associated pivotal mechanisms', 'volume': '2021', 'author': 'M.B. Majnooni', 'year': '2021', 'journal-title': 'Evidence-based Complementary and Alternative Medicine'}, { 'issue': '11', 'key': 'pone.0298201.ref032', 'doi-asserted-by': 'crossref', 'first-page': '3374', 'DOI': '10.3390/molecules26113374', 'article-title': 'Diversity in chemical structures and biological properties of plant ' 'alkaloids', 'volume': '26', 'author': 'S. Bhambhani', 'year': '2021', 'journal-title': 'Molecules'}, { 'issue': '11', 'key': 'pone.0298201.ref033', 'doi-asserted-by': 'crossref', 'first-page': '656', 'DOI': '10.3390/toxins11110656', 'article-title': 'The biological activity of natural alkaloids against herbivores, ' 'cancerous cells and pathogens', 'volume': '11', 'author': 'A. Thawabteh', 'year': '2019', 'journal-title': 'Toxins'}, { 'key': 'pone.0298201.ref034', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/s13002-017-0171-x', 'article-title': 'Rare tradition of the folk medicinal use of Aconitum spp. is kept alive ' 'in Solčavsko, Slovenia', 'volume': '13', 'author': 'M. Povšnar', 'year': '2017', 'journal-title': 'Journal of Ethnobiology and Ethnomedicine'}, { 'issue': '23', 'key': 'pone.0298201.ref035', 'doi-asserted-by': 'crossref', 'first-page': '8655', 'DOI': '10.1021/jf061471t', 'article-title': 'Potato glycoalkaloids and metabolites: roles in the plant and in the ' 'diet', 'volume': '54', 'author': 'M. Friedman', 'year': '2006', 'journal-title': 'Journal of Agricultural and Food Chemistry'}, { 'key': 'pone.0298201.ref036', 'doi-asserted-by': 'crossref', 'first-page': '235', 'DOI': '10.1093/nar/28.1.235', 'article-title': 'The Protein Data Bank', 'volume': '28', 'author': 'H.M. Berman', 'year': '2000', 'journal-title': 'Nucleic Acids Research'}, { 'issue': '1', 'key': 'pone.0298201.ref037', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/1758-2946-4-17', 'article-title': 'Avogadro: an advanced semantic chemical editor, visualization, and ' 'analysis platform', 'volume': '4', 'author': 'M.D. Hanwell', 'year': '2012', 'journal-title': 'Journal of Cheminformatics'}, { 'issue': '5', 'key': 'pone.0298201.ref038', 'doi-asserted-by': 'crossref', 'first-page': '905', 'DOI': '10.1038/nprot.2016.051', 'article-title': 'Computational protein–ligand docking and virtual drug screening with ' 'the AutoDock suite', 'volume': '11', 'author': 'S. Forli', 'year': '2016', 'journal-title': 'Nature Protocols'}, { 'key': 'pone.0298201.ref039', 'article-title': 'GROMACS 2019.1 Manual (2019.1)', 'author': 'A., Hess Lindahl', 'year': '2019', 'journal-title': 'Zenodo'}, { 'key': 'pone.0298201.ref040', 'doi-asserted-by': 'crossref', 'first-page': '111350', 'DOI': '10.1016/j.molliq.2019.111350', 'article-title': 'Molecular dynamics insight into the behaviour of 5-nonylsalicylaldoxime ' 'and its complex with Cu (II) in different diluent/water systems', 'volume': '291', 'author': 'M. Fatehi', 'year': '2019', 'journal-title': 'Journal of Molecular Liquids'}, { 'key': 'pone.0298201.ref041', 'doi-asserted-by': 'crossref', 'first-page': '114908', 'DOI': '10.1016/j.molliq.2020.114908', 'article-title': 'Optimal loading of omecamtiv mecarbil by chitosan: A comprehensive and ' 'comparative molecular dynamics study', 'volume': '322', 'author': 'M.M. Kermani', 'year': '2021', 'journal-title': 'Journal of Molecular Liquids'}, { 'key': 'pone.0298201.ref042', 'doi-asserted-by': 'crossref', 'first-page': '389', 'DOI': '10.1134/S1810232816030085', 'article-title': 'Prediction of thermal conductivity and viscosity of nanofluids by ' 'molecular dynamics simulation', 'volume': '25', 'author': 'M.K. Bushehri', 'year': '2016', 'journal-title': 'Journal of Engineering Thermophysics'}, { 'issue': '9', 'key': 'pone.0298201.ref043', 'doi-asserted-by': 'crossref', 'first-page': '773', 'DOI': '10.1080/1062936X.2013.792877', 'article-title': 'Molecular dynamics simulation study and molecular docking descriptors ' 'in structure-based QSAR on acetylcholinesterase (AChE) inhibitors', 'volume': '24', 'author': 'S. Gharaghani', 'year': '2013', 'journal-title': 'SAR and QSAR in Environmental Research'}, { 'key': 'pone.0298201.ref044', 'doi-asserted-by': 'crossref', 'first-page': '709932', 'DOI': '10.3389/fchem.2021.709932', 'article-title': 'Inhibition of GSK_3β by Iridoid Glycosides of Snowberry (Symphoricarpos ' 'albus) Effective in the Treatment of Alzheimer’s Disease Using ' 'Computational Drug Design Methods', 'volume': '9', 'author': 'M. Eskandarzadeh', 'year': '2021', 'journal-title': 'Frontiers in Chemistry'}, { 'key': 'pone.0298201.ref045', 'doi-asserted-by': 'crossref', 'first-page': '173836', 'DOI': '10.1016/j.ejphar.2020.173836', 'article-title': 'Unraveling the mechanism of arbidol binding and inhibition of ' 'SARS-CoV-2: Insights from atomistic simulations', 'volume': '894', 'author': 'A.K. Padhi', 'year': '2021', 'journal-title': 'European Journal of Pharmacology'}, { 'issue': '1', 'key': 'pone.0298201.ref046', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1186/s43088-021-00107-w', 'article-title': 'Perspectives on plant flavonoid quercetin-based drugs for novel ' 'SARS-CoV-2', 'volume': '10', 'author': 'M. Saakre', 'year': '2021', 'journal-title': 'Beni-Suef University Journal of Basic and Applied Sciences'}, { 'issue': '5', 'key': 'pone.0298201.ref047', 'doi-asserted-by': 'crossref', 'first-page': '1090', 'DOI': '10.1002/prot.26318', 'article-title': 'Structural insights into the substrate‐binding site of main protease ' 'for the structure‐based COVID‐19 drug discovery', 'volume': '90', 'author': 'R. Firouzi', 'year': '2022', 'journal-title': 'Proteins: Structure, Function, and Bioinformatics'}, { 'key': 'pone.0298201.ref048', 'doi-asserted-by': 'crossref', 'first-page': '511', 'DOI': '10.1007/s10822-018-0105-2', 'article-title': 'Protein–ligand interfaces are polarized: discovery of a strong trend ' 'for intermolecular hydrogen bonds to favor donors on the protein side ' 'with implications for predicting and designing ligand complexes', 'volume': '32', 'author': 'S. Raschka', 'year': '2018', 'journal-title': 'Journal of Computer-Aided Molecular Design'}, { 'key': 'pone.0298201.ref049', 'article-title': 'Structure, activity and inhibition of human TMPRSS2, a protease ' 'implicated in SARS-CoV-2 activation', 'author': 'B.J. Fraser', 'year': '2021', 'journal-title': 'BioRxiv'}, { 'issue': '15', 'key': 'pone.0298201.ref050', 'doi-asserted-by': 'crossref', 'first-page': '5638', 'DOI': '10.1080/07391102.2020.1792346', 'article-title': 'Computer-aided screening for potential TMPRSS2 inhibitors: a ' 'combination of pharmacophore modeling, molecular docking and molecular ' 'dynamics simulation approaches', 'volume': '39', 'author': 'M.O. Idris', 'year': '2021', 'journal-title': 'Journal of Biomolecular Structure and Dynamics'}, { 'key': 'pone.0298201.ref051', 'doi-asserted-by': 'crossref', 'first-page': '100758', 'DOI': '10.1016/j.imu.2021.100758', 'article-title': 'Identification of novel TMPRSS2 inhibitors for COVID-19 using ' 'e-pharmacophore modelling, molecular docking, molecular dynamics and ' 'quantum mechanics studies', 'volume': '26', 'author': 'A.A. Alzain', 'year': '2021', 'journal-title': 'Informatics in Medicine Unlocked'}, { 'issue': '5', 'key': 'pone.0298201.ref052', 'doi-asserted-by': 'crossref', 'first-page': '2121', 'DOI': '10.1080/07391102.2020.1835726', 'article-title': 'Prevention of SARS-CoV-2 cell entry: insight from in silico interaction ' 'of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2', 'volume': '40', 'author': 'G.A. Gyebi', 'year': '2022', 'journal-title': 'J Biomol Struct Dyn'}, { 'key': 'pone.0298201.ref053', 'first-page': '1', 'article-title': 'A molecular dynamics study on using of naturally occurring polymers for ' 'structural stabilization of erythropoietin at high temperature', 'author': 'S. Kianipour', 'year': '2021', 'journal-title': 'Journal of Biomolecular Structure and Dynamics'}, { 'key': 'pone.0298201.ref054', 'doi-asserted-by': 'crossref', 'first-page': '105625', 'DOI': '10.1016/j.compbiomed.2022.105625', 'article-title': 'Inhibition of SARS-CoV-2 pathogenesis by potent peptides designed by ' 'the mutation of ACE2 binding region', 'author': 'S. Pourmand', 'year': '2022', 'journal-title': 'Computers in Biology and Medicine'}, { 'key': 'pone.0298201.ref055', 'doi-asserted-by': 'crossref', 'first-page': '91', 'DOI': '10.1016/j.jmgm.2019.06.008', 'article-title': 'Identification of novel small molecules against GSK3β for Alzheimer’s ' 'disease using chemoinformatics approach', 'volume': '91', 'author': 'R. Shukla', 'year': '2019', 'journal-title': 'Journal of Molecular Graphics and Modelling'}], 'container-title': 'PLOS ONE', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://dx.plos.org/10.1371/journal.pone.0298201', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 4, 16]], 'date-time': '2024-04-16T17:58:10Z', 'timestamp': 1713290290000}, 'score': 1, 'resource': {'primary': {'URL': 'https://dx.plos.org/10.1371/journal.pone.0298201'}}, 'subtitle': [], 'editor': [{'given': 'Ahmed A.', 'family': 'Al-Karmalawy', 'sequence': 'first', 'affiliation': []}], 'short-title': [], 'issued': {'date-parts': [[2024, 4, 16]]}, 'references-count': 55, 'journal-issue': {'issue': '4', 'published-online': {'date-parts': [[2024, 4, 16]]}}, 'URL': 'http://dx.doi.org/10.1371/journal.pone.0298201', 'relation': {}, 'ISSN': ['1932-6203'], 'subject': ['Multidisciplinary'], 'container-title-short': 'PLoS ONE', 'published': {'date-parts': [[2024, 4, 16]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit